NYSE$CTEV

Claritev Corp · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Multiplan reported strong first quarter results, exceeding expectations on revenue and Adjusted EBITDA.

MultiPlan Corporation reported Q1 2022 revenues of $298.0 million, a 16.9% increase over Q1 2021. Net income was $44.0 million, and Adjusted EBITDA was $225.4 million. The company processed approximately $31.7 billion in claim charges, identifying potential medical cost savings of approximately $5.6 billion.

  • Revenues of $298.0 million for Q1 2022, an increase of 16.9% over Q1 2021 revenues of $254.9 million.
  • Net income of $44.0 million for Q1 2022, a decrease of 4.1% from Q1 2021 net income of $45.9 million.
  • Adjusted EBITDA of $225.4 million for Q1 2022, an increase of 17.9% over Q1 2021 Adjusted EBITDA of $191.1 million.
  • Free Cash Flow of $170.5 million for Q1 2022, compared to $152.8 million for Q1 2021.

Headline financials

Total Revenue

$298M

Previous: $255M+16.9%
EPS (adj)

$2.80

Previous: $2.80+0.0%
Capital Expenditures

-$24.5M

Previous: -$18.1M-35.0%
Free Cash Flow

$170M

Previous: $153M+11.6%
Net Income

$44M

Previous: $45.9M-4.1%
Operating Income

$117M

Previous: $82.3M+41.8%
Gross Profit

-$47.1M

Previous: -$39.7M-18.5%
Cash & Equivalents

$351M

Previous: $135M+159.8%
Total Assets

$8.28B

Previous: $8.36B-1.0%
Stock-Based Comp

$3.13M

Previous: $968K+223.3%

Revenue & EPS history

Multiplan · Revenue · Quarterly

$298M

Q1 2022+16.9%vs Q1 2021
Beat estimate in 8 of 9 quarters(89%)
ActualEstimate

Forward guidance

The Company is maintaining its Full Year 2022 guidance. The Company anticipates Q2 2022 revenues between $285 million and $295 million and Adjusted EBITDA between $205 million and $215 million.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

-6.5%

Avg return

Earnings day

-5.1%

Avg return

5 days after

-3.8%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+20.8%

Q1 2021

Best reaction

-32.8%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-8.8%+7.7%-2.6%
Q4 2025-31.8%-42.0%-31.4%
Q3 2025+11.8%-5.4%-45.2%
Q1 2025+4.2%+7.5%+95.1%
Q4 2024-32.8%-28.1%-24.8%
Q3 2024-6.5%-3.4%-22.6%
Q2 2024-23.9%-10.2%-47.8%
Q1 2024+10.9%-1.5%-36.6%
Q4 2023-0.9%-13.4%-27.6%
Q3 2023-6.5%-9.7%-14.3%
Q2 2023-8.9%-14.0%-17.8%
Q1 2023-5.4%+21.0%+97.6%
Q4 2022-10.2%+10.0%+6.0%
Q3 2022-27.8%-18.3%-31.1%
Q2 2022-12.4%-13.4%-33.1%
Q1 2022+1.0%+18.4%+27.4%
Q4 2021-8.0%-18.9%-14.4%
Q3 2021+0.2%-11.0%-4.3%
Q2 2021-6.2%-10.5%-20.6%
Q1 2021+20.8%+27.0%+45.5%
Q2 2020+0.5%-0.2%+1.9%
Q4 2020-18.6%-20.3%-19.7%
Q3 2020-4.6%+0.7%+20.8%
Q1 2020+0.5%+0.7%+2.3%
Q4 2019+0.5%+0.7%+2.3%
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro